Are you Dr. Beaver?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 80 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
The Johns Hopkins Hospital
600 North Wolfe Street
Baltimore, MD 21287Phone+1 410-955-5000
Summary
- Dr. Julia Beaver, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and District of Columbia.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
Perelman School of Medicine at the University of PennsylvaniaClass of 2007
Certifications & Licensure
MD State Medical License 2010 - 2026
DC State Medical License 2013 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 41 citationsEnrollment of older adults on oncology trials: An FDA perspective.Harpreet Singh, Julia A. Beaver, Geoffrey Kim, Richard Pazdur
Journal of Geriatric Oncology. 2017-05-01 - 77 citationsFDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial CarcinomaElaine Chang, Chana Weinstock, Lijun Zhang, Rosane Charlab, Sarah E. Dorff
Clinical Cancer Research. 2021-02-15 - 37 citationsFDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer.Suparna Wedam, Lola Fashoyin-Aje, Xin Gao, Erik Bloomquist, Shenghui Tang
Clinical Cancer Research. 2020-03-26
Press Mentions
Targeted Oncology - FDA Cracks down on Dangling Accelerated Approvals in 2021, Pathway Is ScrutinizedDecember 20th, 2021- FDA Posts New Websites on Accelerated Approvals for Cancer DrugsOctober 29th, 2021
- The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
- Join now to see all
